132 related articles for article (PubMed ID: 10807428)
1. The effect of sofalcone on indomethacin-induced gastric ulcers in a Helicobacter pylori-infected gnotobiotic murine model.
Kabir AM; Shimizu K; Aiba Y; Igarashi M; Takagi A; Koga Y
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():223-9. PubMed ID: 10807428
[TBL] [Abstract][Full Text] [Related]
2. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
[TBL] [Abstract][Full Text] [Related]
3. Effect of sofalcone on adherence, production of vacuolating toxin, and induction of interleukin-8 secretion by Helicobacter pylori.
Kamiya S; Osaki T; Kumada J; Yamaguchi H; Taguchi H
J Clin Gastroenterol; 1997; 25 Suppl 1():S172-8. PubMed ID: 9479645
[TBL] [Abstract][Full Text] [Related]
4. A novel in vitro effect of the mucosal protective agent sofalcone--inhibition of chemotactic motility in Helicobacter pylori.
Yoshiyama H; Nakamura H; Okamoto T; Okita K; Nakazawa T
Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():230-6. PubMed ID: 10807429
[TBL] [Abstract][Full Text] [Related]
5. Sofalcone for treatment of Helicobacter pylori infection.
Fujioka T; Murakami K; Kubota T; Kodama R; Honda S; Nasu M
J Gastroenterol; 1996 Nov; 31 Suppl 9():56-8. PubMed ID: 8959521
[TBL] [Abstract][Full Text] [Related]
6. Influence of Helicobacter pylori infection on healing and relapse of acetic acid ulcers in Mongolian gerbils.
Keto Y; Ebata M; Tomita K; Okabe S
Dig Dis Sci; 2002 Apr; 47(4):837-49. PubMed ID: 11991619
[TBL] [Abstract][Full Text] [Related]
7. Plaunotol suppresses interleukin-8 secretion induced by Helicobacter pylori: therapeutic effect of plaunotol on H. pylori infection.
Takagi A; Koga Y; Aiba Y; Kabir AM; Watanabe S; Ohta-Tada U; Osaki T; Kamiya S; Miwa T
J Gastroenterol Hepatol; 2000 Apr; 15(4):374-80. PubMed ID: 10824880
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of sofalcone on tumor necrosis factor-alpha and interleukin-1 beta production in human monocytes stimulated by Helicobacter pylori water extract.
Fujiwara Y; Higuchi K; Fukuda T; Watanabe T; Tominaga K; Arakawa T
Drugs Exp Clin Res; 2001; 27(3):103-6. PubMed ID: 11447767
[TBL] [Abstract][Full Text] [Related]
9. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
Suzuki M; Kitahora T; Nagahashi S; Suzuki H; Mori M; Hibi T; Ishii H
J Clin Gastroenterol; 1998; 27 Suppl 1():S183-6. PubMed ID: 9872519
[TBL] [Abstract][Full Text] [Related]
10. Effects of sofalcone on necrotizing agents-induced gastric lesions and on endogenous prostaglandins in rats stomachs.
Saziki R; Arai I; Isobe Y; Hirose H; Aihara H
J Pharmacobiodyn; 1984 Nov; 7(11):791-7. PubMed ID: 6597872
[TBL] [Abstract][Full Text] [Related]
11. Alteration of basic fibroblast growth factor concentration and immunoreactivity in healing of ethanol-induced gastric mucosal damage: effect of sofalcone.
Nakamura M; Akiba Y; Oda M; Ishii H
J Clin Gastroenterol; 1997; 25 Suppl 1():S13-20. PubMed ID: 9479622
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Helicobacter pylori and nonsteroidal anti-inflammatory drug-induced gastric epithelial injury.
Igarashi M; Takagi A; Jiang X; Hasumi K; Watanabe S; Deguchi R; Miwa T
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():235-9. PubMed ID: 11966547
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
[TBL] [Abstract][Full Text] [Related]
14. [Sofalcone].
Fukuda Y; Shimoyama T
Nihon Rinsho; 2002 Feb; 60 Suppl 2():704-9. PubMed ID: 11979875
[No Abstract] [Full Text] [Related]
15. Effect of 10% ethanol and sofalcone on prostaglandin E2 content, mucus gel thickness, and experimental ulcers in the stomach of developing rats.
Tabata M; Tomomasa T; Itoh K; Morikawa A
Digestion; 1996; 57(1):47-53. PubMed ID: 8626048
[TBL] [Abstract][Full Text] [Related]
16. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Isomoto H; Furusu H; Ohnita K; Wen CY; Inoue K; Kohno S
World J Gastroenterol; 2005 Mar; 11(11):1629-33. PubMed ID: 15786539
[TBL] [Abstract][Full Text] [Related]
17. Cochlospermum regium (Mart. ex Schrank) Pilg.: Evaluation of chemical profile, gastroprotective activity and mechanism of action of hydroethanolic extract of its xylopodium in acute and chronic experimental models.
Arunachalam K; Damazo AS; Pavan E; Oliveira DM; Figueiredo FF; Machado MTM; Balogun SO; Soares IM; Barbosa RDS; Alvim TDC; Ascêncio SD; Martins DTO
J Ethnopharmacol; 2019 Apr; 233():101-114. PubMed ID: 30611907
[TBL] [Abstract][Full Text] [Related]
18. Mouse model of Helicobacter pylori infection: studies of gastric function and ulcer healing.
Konturek PC; Brzozowski T; Konturek SJ; Stachura J; Karczewska E; Pajdo R; Ghiara P; Hahn EG
Aliment Pharmacol Ther; 1999 Mar; 13(3):333-46. PubMed ID: 10102967
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with clarithromycin and sofalcone for eradication of Helicobacter pylori.
Kodama R; Fujioka T; Fujiyama K; Kawasaki H; Kubota T; Nasu M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S125-8. PubMed ID: 7735929
[TBL] [Abstract][Full Text] [Related]
20. Mouririelliptica: validation of gastroprotective, healing and anti-Helicobacter pylori effects.
Moleiro FC; Andreo MA; Santos Rde C; Moraes Tde M; Rodrigues CM; Carli CB; Lopes FC; Pellizzon CH; Carlos IZ; Bauab TM; Vilegas W; Hiruma-Lima CA
J Ethnopharmacol; 2009 Jun; 123(3):359-68. PubMed ID: 19501267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
